Elevated UTP and CTP content in cultured neurons from HPRT-deficient transgenic mice
- 48 Downloads
Hypoxanthine-guanine phosphoribosyltransferase (EC 220.127.116.11.; HPRT) catalyzes the salvage synthesis of inosine-5′-monophosphate (IMP) and guanosine-5′-monophosphate (GMP) from the purine bases hypoxanthine and guanine, respectively. Complete deficiency of HPRT activity is associated with the Lesch-Nyhan syndrome (LNS), characterized by excessive purine production and severe neurological manifestations. The etiology of the metabolic consequences of HPRT deficiency is clarified, but that of the neurological manifestations is not yet understood. HPRT-deficient mice represent an experimental animal model of LNS. In search for a possible metabolic abnormality in LNS brains, connecting the neurological deficit to HPRT deficiency, the purine and pyrimidine nucleotide content of cultured neurons, prepared from HPRT-deficient transgenic mice, was now determined. The HPRT-deficient neuronal cultures exhibited a significantly elevated content of the pyrimidine nucleotides UTP (1.33-fold the normal level, p=0.0002) and CTP (1.28-fold the normal level, p=0.02), but normal content of the purine nucleotides ATP and GTP. This abnormality in neuronal pyrimidine nucleotide content may be associated with the pathophysiology of the neurological deficit in LNS.
Index EntriesPurine nucleotides pyrimidine nucleotides Lesch-Nyhan syndrome (LNS) Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency neuronal cultures HPRT-deficient transgenic mice
Unable to display preview. Download preview PDF.
- Breadfield X. O. and Cambi F. (1987) Purine metabolism: Lesch-Nyhan syndrome. Ann. Rev. Neurosci. 10, 533–594.Google Scholar
- Jinnah H. A., Woicik B. E., Hunt M., Narang N., Lee K. Y., Goldstein M., et al. (1994) Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease, J. Neurosc. 14, 1164–1175.Google Scholar
- Kelley W. N. and Wyngaarden J. B. (1983) Clinical syndromes associated with hypoxanthine-guanine phosphoribosyltransferase deficiency, in The Metabolic Basis of Inherited Disease (Stanbury, J. B., et al., eds.), McGraw-Hill, New York, pp. 1115–1143.Google Scholar
- Rossiter B. J. F. and Caskey C. T. (1995) Hypoxanthine-guanine phosphoribosyltransferase deficiency: Lesch-Nyhan syndrome and gout, in The Metabolic and Molecular Basis of Inherited Disease, 7th ed. (Scriver C. R., et al., eds.), McGraw-Hill, New York, pp. 1679–1706.Google Scholar
- Watts R. W. E., Spellacy E., Gibbs D. A., Allsop J., McKeran R. O., and Salvin G. E. (1982) Clinical postmortem, biochemical and therapeutic observations on the Lesch-Nyhan syndrome with particular reference to neurological manifestations. Quart. J. Med. 201, 43–78.Google Scholar